IGC Pharma, Inc. (IGC) bonds
IGCNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 2/309% above fair value
$0.18−0.01 (-4.61%)
Close on Nov 13, 2026Market cap $18.20MP/E –Yield –
Debt
Borrowings on the balance sheet, Sep 30, 2026
Total debt
$128.00K
Long-term debt
Net debt
-$249.00K
After $377.00K of cash
Implied interest rate
–
FY2026 interest ÷ average debt
Interest coverage
–
FY2026 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
Notes and loans outstanding
As tagged in IGC Pharma's 10-Q for the period ended Jun 30, 2026
| Issue | Coupon | Matures | Amount issued | Carrying value |
|---|---|---|---|---|
| VFG Note | – | Feb 28, 2027 | $591.00K | $492.00K |
| First Fire Note | – | – | $346.00K | $289.00K |
| IBOR | 1.20% | – | – | – |
| ODK Capital LLC | 31.90% | – | – | – |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
See a number that looks wrong?